Leonurine Attenuates Streptozotocin-Induced Diabetic Nephropathy in Rats by Mitigating Dyslipidemia and Inflammation

ABSTRACT

Background Diabetic Nephropathy (DN) is one of the serious complications associated with a prolonged diabetic condition. DN continues to be the primary cause of morbidity and mortality among diabetic patients globally. Objectives The objective of the current work is to study the nephroprotective properties of leonurine in the diabetic nephropathy model. Materials and Methods The experimental rats were induced with DN through an administration of 65 mg/kg of Streptozotocin (STZ) and the DN rats were treated with leonurine for 12 weeks. Following the treatment period, the blood glucose, insulin and glycosylated Hemoglobin (HbA1c) levels were evaluated. The renal function markers, including creatinine, kidney injury molecule, ROS level, lipid profiles and pro-inflammatory cytokine levels, were examined using the kits. The renal tissues of the experimental rats were subjected to the histological studies. Results The outcomes of the present work found that the leonurine treatment considerably increased the insulin levels, decreased blood glucose and HbA1c levels and decreased ROS production in the DN rats. In the DN rats, the treatment of leonurine significantly reduced the inflammatory markers, renal fibrotic markers, kidney dysfunction markers and lipid markers. The histological analysis results also confirmed leonurine's therapeutic effects against DN in rats. Conclusion The current findings suggest that leonurine has the capacity to be a talented candidate to treat DN.

KEYWORDS

• Renal fibrosis
• Hyperglycemia
• Leonurine
• Insulin
• Dyslipidemia

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.58.4.125Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 58, ISSUE 4Rutaecarpine Induces Apoptosis via a Mitochondrial Membrane-Mediated Pathway in the Human Liver Cancer Cells (HepG2)Xiaoyuan Zhuang, Yatian Wang, Shen Lin, Guoshan Zhang · pp. 1070–1076Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 4The Therapeutic Effects of QihaPingchuan Capsule in Combination with Triple Therapy (ICS+LABA+LAMA) on Chronic Obstructive Pulmonary DiseaseZhijun Dong, Shujiang Dong, Jiang Li, Yanli Zhu, Zhiyong Ma, Yupei Hou, Weidong Zhao · pp. 1077–1083Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 4Unveiling Ethical AI: An In-Depth Bibliometric and Visual ExplorationQihui Yuan, Tingxuan Chen, Qing Yang, Zongming Zhang · pp. 1084–1101Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 4Berberine’s Therapeutic Prospects in Parkinson’s Disease: A Spotlight on Cholesterol Regulation for Cognitive ImprovementT Lakshmi Narayanan, Dithu Thekkekkara, Manasa Renu Srivalli Chattu, Amrita Babu, Sreenivasulu Naidu Kondaveeti, SK. Meheroonisha, Thummuru Ekshita Sai · pp. 1102–1109Original ArticleSame type: Article